Skip to Content
Chinese Medicine Regulatory Office
Site Menu
Home
>
What's New
>
Public Letter & Information
> Letter and Information to Chinese Medicines Traders from Department of Health
Letter and Information to Chinese Medicines Traders from Department of Health
Year 2023
Year 2021
Year 2020
Year 2017
Year 2016
Year 2015
Year 2014
Year 2013
Year 2012
Year 2011
Year 2010
Year 2009 or Before
Latest arrangement on revised limits of heavy metals and toxic elements in Chinese herbal medicines (Chinese version only)
(20 December 2023)
Consultation for the Amendment of Schedule 1 and Schedule 2 of the Chinese Medicine Ordinance (Cap. 549)
(13 January 2023)
Amendments to the limits for harmful residues in Chinese herbal medicines and related measures for implementation in Hong Kong
(Chinese version only) (16 December 2021)
Letter to Wholesalers of Chinese Herbal Medicines, Retailers of Chinese Herbal Medicines and Manufacturers of Proprietary Chinese Medicines from Department of Health: Amendments to the limits for harmful residues in Chinese herbal medicines and related measures for implementation in Hong Kong (Revised Proposal)
(Chinese version only) (21 October 2021)
Setting limits of sulphur dioxide residue in Chinese herbal medicines and revised measures for implementation (Chinese version only)
(27 May 2021)
Powerpoint of the consultation on amendments to the limits for harmful residues in Chinese herbal medicines and related measures for implementation in Hong Kong
(Chinese version only) (20 April 2021)
Consultation document of the consultation on amendments to the limits for harmful residues in Chinese herbal medicines and related measures for implementation in Hong Kong
(31 March 2021)
Use Chinese herbal medicines safely
(Barrier-free)
Storage of Chinese Herbal Medicines (Chinese version only)
(Barrier-free)
Letter to Wholesalers of Proprietary Chinese Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines (Chinese version only)
(6 October 2020)
Letter to Wholesalers of Chinese Herbal Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines and Chinese Herbal Medicines and Sale of Chinese Herbal Medicines via the Internet (Chinese version only)
(6 October 2020)
Letter to Retailers of Chinese Herbal Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines and Chinese Herbal Medicines and Sale of Chinese Herbal Medicines via the Internet (Chinese version only)
(6 October 2020)
Letter to retailers of Chinese herbal medicines from Department of Health on "Supplies for maintaining good personal and environmental hygiene"(Chinese version only)
(3 February 2020)
Briefing Session on "Easily Confused Herbal Medicines in Hong Kong" 2017 (No.2) will be launched in December 2017 (For Chinese Medicine Traders)
(Chinese version only) (20 November 2017)
Ensuring the sulphur dioxide content in Chinese herbal medicines meeting quality requirements
(Chinese version only) (2 November 2017)
Briefing Session on "Easily Confused Herbal Medicines in Hong Kong" 2017 (No.1) will be launched in June 2017 (For Chinese Medicine Trader)
(Chinese version only) (24 May 2017)
Briefing Session on "Easily Confused Herbal Medicines in Hong Kong" 2016 (No.2) will be launched in December 2016 (For Chinese Medicine Traders)
(Chinese version only) (14 November 2016)
Letter to Chinese Medicines Traders from Department of Health : Handling of moxa products
(Chinese version only) (27 June 2016)
Briefing Session on "Easily Confused Herbal Medicines in Hong Kong" 2016/17 (No.1) will be launched in June 2016 (For Chinese Medicine Traders)(Chinese version only)
(11 May 2016)
Briefing Session on "Easily Confused Herbal Medicines in Hong Kong" 2014/15 (No.3) will be launched in December 2015 (For Chinese Medicine Traders) (Chinese version only)
(16 November 2015)
Arrangement upon end of test reports submission period for transitional registration of proprietary Chinese medicine" (Chinese version only)
(12 November 2015)
Briefing Session on "Easily Confused Herbal Medicines in Hong Kong" 2014/15 (No.2) will be launched in June 2015 (For Chinese Medicine Traders) (Chinese version only)
(28 May 2015)
Arrangement for holders of HKP who fail to submit the test reports by the expiry date of submission
(18 May 2015)
Arrangements upon the deadline of submission of test reports for transitional registration of proprietary Chinese medicine
(13 May 2015)
Briefing Sessions on “Easily Confused Herbal Medicines in Hong Kong” 2014/15 will be launched in December 2014 (For Chinese Medicine Traders) (Chinese version only)
(18 November 2014)
Press Release of Department of Health: DH closely monitors outbreak of Ebola virus disease in Democratic Republic of the Congo and updates affected areas
(28 August 2014)
Press Release of Department of Health: DH closely monitors overseas outbreaks of Ebola virus disease
(30 July 2014)
Legal requirements to register pharmaceutical products and proprietary Chinese medicines
(14 April 2014)
Briefing Sessions on “Easily Confused Herbal Medicines in Hong Kong” Year 2013/14 will be launched in April 2014 (For Chinese Medicine Traders) (Chinese version only)
(14 March 2014)
Letter to Chinese Medicines traders from Department of Health : The relevant information required to be displayed on labels and package inserts of pCm containing “Radix Polygoni Multiflori" (Chinese version only)
(3 March 2014)
Letter to Chinese medicines traders associations from Department of Health : The relevant information required to be displayed on labels and package inserts of pCm containing “Radix Polygoni Multiflori" (Chinese version only)
(3 March 2014)
Letter to Chinese Medicines traders from Department of Health : Addition of clauses on proper use of product to package inserts of proprietary Chinese medicines containing "Tremolitum" (Chinese version only)
(3 March 2014)
Letter to Chinese medicines traders associations from Department of Health : Addition of clauses on proper use of product to package inserts of proprietary Chinese medicines containing "Tremolitum" (Chinese version only)
(3 March 2014)
Letter to Chinese medicines traders associations from Department of Health:Prevention of Influenza (Chinese version only)
(10 January 2014)
Vigilance Against Seasonal Influenza
(10 January 2014)
Letter and Information to Chinese Medicines Traders from Department of Health: Briefing Sessions on “Easily Confused Herbal Medicines in Hong Kong” Year 2013/14 will be launched in January 2014 (For Chinese Medicine Traders) (Chinese version only)
(31 December 2013)
Letter to Chinese medicines traders associations and Chinese medicines traders from Department of Health:A Confirmed Case of Human Infection with Avian Influenza A (H7N9) virus in Hong Kong and Activation of Serious Response Level of Government's Preparedness Plan (Chinese version only)
(3 December 2013)
Added colourants found in certain Chinese herbal medicines in China (For Chinese Medicines Traders) (Chinese version only)
(21 October 2013)
Briefing Sessions on “Easily Confused Herbal Medicines in Hong Kong” Year 2013/14 will be launched in October (For Chinese Medicines Traders) (Chinese version only)
(2 September 2013)
Revised arrangement on the submission of test reports for transitional registration of proprietary Chinese Medicine (Chinese version only)
(26 June 2013)
Briefing Sessions on “Easily Confused Herbal Medicines in Hong Kong” Year 2013/14 will be launched in July (For Chinese Medicines Traders) (Chinese version only)
(18 June 2013)
Letter to Chinese medicines traders associations and Chinese medicines traders from Department of Health:Update on Cases of Human Infection with Avian Influenza A(H7N9) (Chinese version only)
(5 April 2013)
Letter to Chinese medicines traders associations and Chinese medicines traders from Department of Health:Case of Severe Respiratory Disease associated with Novel Coronavirus (Chinese version only)
(27 September 2012)
Letter to Chinese Medicines Traders from Department of Health:(To Wholesalers of Chinese herbal medicines) Related to the source of imported processed herbal medicines (Chinese version only)
(10 September 2012)
Letter to Chinese Medicines Traders from Department of Health:(To Manufacturers of proprietary Chinese medicines) Related to the source of imported processed herbal medicines (Chinese version only)
(10 September 2012)
Letter to Chinese Medicines Traders from Department of Health:(To Wholesalers of proprietary Chinese medicines) Related to the source of imported processed herbal medicines (Chinese version only)
(10 September 2012)
Letter to Chinese Medicines Traders from Department of Health:(To Retailers of Chinese herbal medicines) Related to the source of imported processed herbal medicines (Chinese version only)
(10 September 2012)
Guidelines on Undesirable Medical Advertisements Ordinance
(1 June 2012)
Letter to Chinese Medicines Traders from Department of Health:Commencement of the Undesirable Medical Advertisements (Amendment) Ordinance 2005
(22 February 2012)
Letter to Chinese Medicines Traders from Department of Health : Suspension of Providing Declaration of Flavouring Agents for Orally Consumed Proprietary Chinese Medicine Products (Chinese version only)
(19 January 2012)
Letter to Chinese Medicine Traders from Department of Health : Arrangement for processing application of Proprietary Chinese Medicine Import and Export Licence with effective from 1 Feb. 2012(Chinese version only)
(09 January 2012)
- Guidelines for application of Proprietary Chinese Medicine Import and Export Licence with effective from 1 Feb. 2012(Chinese version only)
Announcement in the Public Interest of provisions on label and package insert for proprietary Chinese medicine
(1 December 2011)
Letter to Chinese Medicines Traders from Department of Health: Declaration of the origin of flavouring agent in products in oral preparation (Chinese version only)
(2 June 2011)
Letter to Chinese Medicines Traders from Department of Health: DEHP (Di(2-ethylhexyl)phthalate) and DINP (diisononyl phthalate) (Chinese version only)
(1 June 2011)
Letter to Chinese Medicines Traders from Department of Health: DEHP (Di(2-ethylhexyl)phthalate) and DINP (diisononyl phthalate) (Chinese version only)
(30 May 2011)
Letter to Chinese Medicine Retailers about Commencement of the Mandatory Registration of Proprietary Chinese Medicines and related issue (Chinese version only) (24 November 2010)
Letter to Chinese Medicine Traders about Commencement of the Mandatory Registration of Proprietary Chinese Medicines and related issue (Chinese version only) (11 November 2010)
Briefing seminar for commencement of relevant provisions for mandatory registration of pcm (Chinese version only)
(31 May 2010)
Briefing on Product Quality Documents and Guidelines on Labels and Package Inserts of Proprietary Chinese Medicines (Chinese version only)
(11&18 July 2009)
The Use of Chinese Herbal Medicine -- Medulla Junci
(1 December 2008)
Reports of Adverse Events after Taking a Health Product for Improvement of Sexual Function
(5 February 2008)